HIV-prevalence in Tuberculosis Patients in Germany, 2002-2009: an Estimation Based on HIV and Tuberculosis Surveillance Data

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Nov 13

PMID 23145087

Citations 5

Authors

Lena Fiebig

Christian Kollan

Barbara Hauer

Barbara Gunsenheimer-Bartmeyer

Matthias An der Heiden

Osamah Hamouda

Walter Haas

Affiliations

Soon will be listed here.

Abstract

Tuberculosis (TB) and HIV comorbidity is a major challenge in TB prevention and control but difficult to assess in Germany as in other countries, where data confidentiality precludes notifying the HIV status of TB patients. We aimed to estimate the HIV-prevalence in TB patients in Germany, 2002-2009, and to characterize the HIV/TB patients demographically. Data from the long-term observational open multicentre cohort ClinSurv HIV were used to identify incident TB in HIV-positive individuals. We assessed the cohort's coverage for the nationwide HIV-positive population by contrasting ClinSurv HIV patients under antiretroviral therapy (ART) with national HIV patient numbers derived from ART prescriptions (data by Insight Health; available for 2006-2009). The HIV-prevalence in TB patients was calculated as the number of HIV/TB cases projected for Germany over all culture-positive TB notifications. From 2002 to 2009, 298 of 15,531 HIV-positive patients enrolled in the ClinSurv HIV cohort were diagnosed with TB. A 21% cohort coverage was determined. The annual estimates of the HIV-prevalence in TB patients were on average 4.5% and ranged from 3.5% (95%CI 2.3-5.1%) in 2007 to 6.6% (95%CI 5.0-8.5%) in 2005. The most recent estimate for 2009 was 4.0% (95%CI 2.6-5.9%). The 298 HIV/TB patients were characterized by a male-to-female ratio of 2.1, by a median age of 38 years at TB diagnosis, and by 59% of the patients having a foreign origin, mainly from Subsahara Africa. We provide, to our knowledge, the first estimate of the HIV-prevalence in TB patients for Germany by joint evaluation of anonymous HIV and TB surveillance data sources. The identified level of HIV in TB patients approximates available surveillance data from neighbouring countries and indicates a non-negligible HIV/TB burden in Germany. Our estimation approach is valuable for epidemiological monitoring of HIV/TB within the current legal frameworks.

Citing Articles

Prevalence of primary anti-tuberculosis drug resistance at the tertiary center in Saudi Arabia and associated risk factors.

Al-Shahrani M, Hakami M, Younis M, Fan H, Jeraiby M, Alraey Y Saudi Med J. 2021; 42(7):728-734.

PMID: 34187916 PMC: 9195529. DOI: 10.15537/smj.2021.42.7.20200797.

Factors associated with hospitalization and death among TB/HIV co-infected persons in Porto Alegre, Brazil.

Rossetto M, Brand E, Rodrigues R, Serrant L, Teixeira L PLoS One. 2019; 14(1):e0209174.

PMID: 30601842 PMC: 6314623. DOI: 10.1371/journal.pone.0209174.

Drug resistant tuberculosis in Saudi Arabia: an analysis of surveillance data 2014-2015.

Al Ammari M, Al Turaiki A, Al Essa M, Kashkary A, Eltigani S, Ahmed A Antimicrob Resist Infect Control. 2018; 7:12.

PMID: 29387346 PMC: 5778613. DOI: 10.1186/s13756-018-0306-4.

Higher Rate of Tuberculosis in Second Generation Migrants Compared to Native Residents in a Metropolitan Setting in Western Europe.

Marx F, Fiebig L, Hauer B, Brodhun B, Glaser-Paschke G, Magdorf K PLoS One. 2015; 10(6):e0119693.

PMID: 26061733 PMC: 4465484. DOI: 10.1371/journal.pone.0119693.

Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors.

Karo B, Haas W, Kollan C, Gunsenheimer-Bartmeyer B, Hamouda O, Fiebig L BMC Infect Dis. 2014; 14:148.

PMID: 24646042 PMC: 3994660. DOI: 10.1186/1471-2334-14-148.

References

Selwyn P, Hartel D, Lewis V, Schoenbaum E, Vermund S, Klein R . A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989; 320(9):545-50. DOI: 10.1056/NEJM198903023200901. View

. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992; 41(RR-17):1-19. View

Bucher H, Griffith L, Guyatt G, Sudre P, Naef M, Sendi P . Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS. 1999; 13(4):501-7. DOI: 10.1097/00002030-199903110-00009. View

Migliori G, Centis R . Problems to control TB in eastern Europe and consequences in low incidence countries. Monaldi Arch Chest Dis. 2003; 57(5-6):285-90. View

Pawlowski A, Jansson M, Skold M, Rottenberg M, Kallenius G . Tuberculosis and HIV co-infection. PLoS Pathog. 2012; 8(2):e1002464. PMC: 3280977. DOI: 10.1371/journal.ppat.1002464. View

Neves L, Canini S, Reis R, Santos C, Gir E . [Aids and tuberculosis: coinfection from the perspective of the quality of life of patients]. Rev Esc Enferm USP. 2012; 46(3):704-10. DOI: 10.1590/s0080-62342012000300024. View

Batzing-Feigenbaum J, Kollan C, Kuhne A, Matysiak-Klose D, Gunsenheimer-Bartmeyer B, Hamouda O . Cohort profile: the German ClinSurv HIV project--a multicentre open clinical cohort study supplementing national HIV surveillance. HIV Med. 2010; 12(5):269-78. DOI: 10.1111/j.1468-1293.2010.00879.x. View

de Colombani P, Banatvala N, Zaleskis R, Maher D . European framework to decrease the burden of TB/HIV. Eur Respir J. 2004; 24(3):493-501. DOI: 10.1183/09031936.04.00064504. View

Lazarus J, Olsen M, Ditiu L, Matic S . Tuberculosis-HIV co-infection: policy and epidemiology in 25 countries in the WHO European region. HIV Med. 2008; 9(6):406-14. DOI: 10.1111/j.1468-1293.2008.00567.x. View

10.

Girardi E, Antonucci G, Vanacore P, Libanore M, Errante I, Matteelli A . Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS. 2000; 14(13):1985-91. DOI: 10.1097/00002030-200009080-00015. View

11.

Lawn S, Bekker L, Miller R . Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis. 2005; 5(6):361-73. DOI: 10.1016/S1473-3099(05)70140-7. View

12.

Day J, Grant A, Fielding K, Morris L, Moloi V, Charalambous S . Does tuberculosis increase HIV load?. J Infect Dis. 2004; 190(9):1677-84. DOI: 10.1086/424851. View

13.

Kipp A, Pungrassami P, Stewart P, Chongsuvivatwong V, Strauss R, Van Rie A . Study of tuberculosis and AIDS stigma as barriers to tuberculosis treatment adherence using validated stigma scales. Int J Tuberc Lung Dis. 2011; 15(11):1540-5, i. PMC: 3753693. DOI: 10.5588/ijtld.10.0273. View

14.

Rodger A, Story A, Fox Z, Hayward A . HIV prevalence and testing practices among tuberculosis cases in London: a missed opportunity for HIV diagnosis?. Thorax. 2009; 65(1):63-9. DOI: 10.1136/thx.2009.122754. View

15.

Pimpin L, Drumright L, Kruijshaar M, Abubakar I, Rice B, Delpech V . Tuberculosis and HIV co-infection in European Union and European Economic Area countries. Eur Respir J. 2011; 38(6):1382-92. DOI: 10.1183/09031936.00198410. View

16.

Balabanova Y, Gilsdorf A, Buda S, Burger R, Eckmanns T, Gartner B . Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011. PLoS One. 2011; 6(10):e25691. PMC: 3186774. DOI: 10.1371/journal.pone.0025691. View

17.

Small P, Shafer R, Hopewell P, Singh S, Murphy M, Desmond E . Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med. 1993; 328(16):1137-44. DOI: 10.1056/NEJM199304223281601. View

18.

Muller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M . Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis. 2010; 10(4):251-61. PMC: 4183458. DOI: 10.1016/S1473-3099(10)70026-8. View

19.

Fernandez de la Hoz K, Manissero D . A framework action plan to fight tuberculosis in the European Union. Euro Surveill. 2008; 13(12). DOI: 10.2807/ese.13.12.08074-en. View

20.

Kruijshaar M, Pimpin L, Abubakar I, Rice B, Delpech V, Drumright L . The burden of TB-HIV in the EU: how much do we know? A survey of surveillance practices and results. Eur Respir J. 2011; 38(6):1374-81. DOI: 10.1183/09031936.00198310. View